Status:
COMPLETED
Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
To investigate safety, tolerability, and pharmacokinetics of multiple rising oral doses of BI 1015550 in healthy male volunteers
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 1\. Healthy male subjects
- Exclusion criteria:
- Any relevant deviation from healthy conditions
- Subjects unable to understand or to comply with study requirements
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01835899
Start Date
April 1 2013
End Date
June 1 2013
Last Update
January 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1305.2.1 Boehringer Ingelheim Investigational Site
Mannheim, Germany